New Variants of SEL1L in Cancer Cells
Author Information
Author(s): Cattaneo Monica, Lotti Lavinia Vittoria, Martino Simone, Alessio Massimo, Conti Antonio, Bachi Angela, Mariani-Costantini Renato, Biunno Ida
Primary Institution: Institute for Biomedical Technologies, National Research Council, Milan, Italy
Hypothesis
The study investigates the secretion and role of novel SEL1L variants in human cancer cells under ER stress.
Conclusion
The two new SEL1L variants, p38 and p28, are secreted in cancer cells and may serve as potential diagnostic markers or therapeutic targets.
Supporting Evidence
- p38 and p28 are more stable than the canonical SEL1LA protein.
- Secretion of p38 is significantly increased under ER stress conditions.
- P28 is only detected in the poorly differentiated SKBr3 breast cancer line after ER stress.
Takeaway
Scientists found two new proteins in cancer cells that help them deal with stress. These proteins could be important for understanding and treating cancer.
Methodology
The study involved biochemical and RNA interference studies in various human cancer cell lines to analyze the expression and secretion of SEL1L variants.
Limitations
The study primarily focuses on in vitro models, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website